Ebola Virus Disease, Vaccines, Therapeutics, Transmission, and Long-Term Sequelae: Scoping Review with ☸️SAIMSARA
SAIMSARA Journal · 06.06.2026 · 1 (7)
DOI: 10.62487/saimsara976931fc ↗Kurz gefasst
Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 06.06.2026. Die Arbeit nennt 810 Literaturangaben.
Abstract (Originalsprache)
To map and synthesize the original research evidence on Ebola virus disease, including clinical presentation and prognosis, transmission and outbreak control, diagnostics, vaccines, therapeutics, pathophysiology, survivor sequelae, health-system effects, and implementation challenges. The review uses 810 references and builds its evidence map from 2251 original studies with 4785212 total participants/sample observations (topic-deduplicated ΣN). This scoping review indicates that Ebola virus disease outcomes are consistently shaped by viral load, age, organ dysfunction, and the timeliness of effective care, with case fatality reaching 62.9% across the 2013–2016 West African epidemic and exceeding 80% in children under five years and older adults. The evidence supports a role for rVSV-ZEBOV vaccination in reducing both infection risk and mortality among confirmed cases, while monoclonal antibody therapies MAb114 and REGN-EB3 were associated with substantially lower mortality than ZMapp in a randomized trial. Transmission control depends on rapid diagnosis, contact tracing, safe burial, and community trust, yet persistent viral reservoirs in immune-privileged sites and documented relapse events underscore the need for sustained survivor monitoring. The mapped literature highlights that health-system resilience, infection prevention infrastructure, and community engagement are critical modifiers of outbreak trajectory, though evidence from non-outbreak and high-resource settings remains limited. Future research should prioritize standardized longitudinal cohort designs with extended follow-up to resolve uncertainties around long-term sequelae, viral persistence, and the durability of vaccine- and treatment-induced protection.
Zitieren
APA
(2026). Ebola Virus Disease, Vaccines, Therapeutics, Transmission, and Long-Term Sequelae: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(7). https://doi.org/10.62487/saimsara976931fc
Vancouver
Ebola Virus Disease, Vaccines, Therapeutics, Transmission, and Long-Term Sequelae: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(7). doi:10.62487/saimsara976931fc
BibTeX
@article{euvimed2026,
title = {Ebola Virus Disease, Vaccines, Therapeutics, Transmission, and Long-Term Sequelae: Scoping Review with ☸️SAIMSARA},
journal = {SAIMSARA Journal},
year = {2026},
volume = {1},
number = {7},
doi = {10.62487/saimsara976931fc}
}
EUVIMED